SCHEMBL1371369

SCHEMBL1371369

CCCCCCCCC#CC/C=C/CCCCC(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 5/20 0.70
TERT O14746 3/20 0.70
PTPN1 P18031 3/20 0.70
PPARG P37231 3/20 0.70
PPARD Q03181 3/20 0.70
PPARA Q07869 3/20 0.70
HMGCR P04035 3/20 0.70
MAPT P10636 2/20 0.70
BLM P54132 2/20 0.70
HSD17B10 Q99714 2/20 0.70
FABP4 P15090 2/20 0.70
F7 P08709 2/20 0.70
F3 P13726 2/20 0.70
DUSP3 P51452 2/20 0.70
GMNN O75496 1/20 0.70
USP2 O75604 1/20 0.70
LMNA P02545 1/20 0.70
CYP1A2 P05177 1/20 0.70
POLB P06746 1/20 0.70
CYP2C9 P11712 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL41374 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL1738166 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL27039218 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL269350 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL1374586 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL269349 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL1374589 1.00 PTPN7 (0.70) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL10918369 0.95 PTPN7 (0.67) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL7594655 0.94 PPARG (0.71) PTPN7TERTPTPN1PPARGPPARD
SCHEMBL7589866 0.94 PPARG (0.71) PTPN7TERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140099354-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS Dietz, Ulrich (DE) 2014-04-10 US claimed
US-20130039956-A1 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS Dietz, Ulrich (DE) 2013-02-14 US claimed
EP-2547322-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS Dietz, Ulrich (DE) 2013-01-23 EP claimed
WO-2011113507-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS DIETZ ULRICH (DE) 2011-09-22 WO claimed
CN-107823721-B Balloon surface coating 德国凯德诺有限责任公司 2021-01-29 CN disclosed
CN-107823719-B Balloon surface coating 德国凯德诺有限责任公司 2021-01-29 CN disclosed
CN-107823720-B Balloon surface coating 德国凯德诺有限责任公司 2021-01-29 CN disclosed
CN-106488970-B Method and use for refining a lipid phase 德雷伊利林PVG有限责任两合公司 2020-12-15 CN disclosed
EP-3469046-A1 AQUEOUS EXTRACTION PROCESS FOR THE RECOVERY OF MUCILAGE AND DEMULSIFICATION Drei Lilien Pvg GmbH&Co. KG (DE) 2019-04-17 EP disclosed
US-20170107449-A1 Method and Device for Processing an Organic Oil in Steps GEA WESTFALIA SEPARATOR GROUP GMBH (DE) 2017-04-20 US disclosed
US-9579423-B2 Balloon catheter with a sirolimus coated catheter balloon for controlled release of sirolimus Cardionovum S.P.z.o.o (PL) 2017-02-28 US disclosed
EP-3042718-A1 DEVICE FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO- OR NANOEMULSIFICATION Dietz, Ulrich (DE) 2016-07-13 EP disclosed
US-20090285888-A1 DERIVATIVES OF DIHYDROXYPHENYLALANINE ELLNEUROXX LTD. (DE) 2009-11-19 US disclosed
US-20090054837-A1 Coating Method for a Folded Balloon B. BRAUN MELSUNGEN AG (DE) 2009-02-26 US disclosed
US-7417034-B2 Pharmaceutically active uridine esters TROMMSDORFF GMBH & CO. KG ARZENEIMITTEL (DE) 2008-08-26 US disclosed
US-20080038307-A1 Biocompatible Coating, Method, and Use of Medical Surfaces HEMOTEQ AG (DE) 2008-02-14 US disclosed
US-7247697-B2 Coating compositions for use in golf balls ACUSHNET COMPANY (US) 2007-07-24 US disclosed
US-20060228250-A1 Method and composition for neutralizing odors RID ODOR ENTERPRISES, L.P. 2006-10-12 US disclosed
WO-2006102052-A2 METHOD AND COMPOSITION FOR NEUTRALIZING ODORS RIDODOR INC. (US) 2006-09-28 WO disclosed
US-20060089419-A1 Coating compositions for use in golf balls JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090285888-A1 DERIVATIVES OF DIHYDROXYPHENYLALANINE HTT, NLN, SNCA PTPN7 3105/4885TERT 3906/4885PTPN1 3052/4885
US-20130039956-A1 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS NOS1, NOS2, NOS3 PTPN7 1190/4885TERT 3447/4885PTPN1 772/4885
US-20140099354-A1 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF NITROCARBOXYLIC ACID-CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS PHOSPHO1, PTDSS1, LIPG PTPN7 1369/4885TERT 4365/4885PTPN1 1059/4885
US-20080038307-A1 Biocompatible Coating, Method, and Use of Medical Surfaces ALOX5, CD68, CD14 PTPN7 3627/4885TERT 2982/4885PTPN1 4455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.